ASMB vs RMD · rev $21.6M vs P/E 29, rev $5.65B
Assembly Biosciences Inc (ASMB) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Assembly Biosciences Inc (ASMB) is a biotechnology company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported ASMB revenue for 2026-06-30 was $21.6M. Net income was -$12.9M. ASMB currently screens at market cap $143.0M.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
ASMB currently screens at market cap $143.0M. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the ASMB and RMD stock pages for the full models.
Not investment advice.